Evidence map›Paper›PMID 30775230›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

One-Step Generation of a Drug-Releasing Hydrogel Microarray-On-A-Chip for Large-Scale Sequential Drug Combination Screening.

Seo Woo Song, Su Deok Kim, Dong Yoon Oh, Yongju Lee, Amos Chungwon Lee, Yunjin Jeong, Hyung Jong Bae, Daewon Lee, Sumin Lee, Jiyun Kim and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Fish Capsules: A System for High-Throughput Screening of Combinatorial Drugs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seo Woo SongDepartment of Electrical and Computer Engineering Seoul National University Seoul 08826 South Korea.
Su Deok KimDepartment of Electrical and Computer Engineering Seoul National University Seoul 08826 South Korea.
Dong Yoon OhInstitutes of Entrepreneurial BioConvergence Seoul National University Seoul 08826 South Korea.
Yongju LeeDepartment of Electrical and Computer Engineering Seoul National University Seoul 08826 South Korea.
Amos Chungwon LeeDepartment of Mechanical Science and Engineering University of Illinois at Urbana-Champaign Urbana IL 61801 USA.
Yunjin JeongDepartment of Electrical and Computer Engineering Seoul National University Seoul 08826 South Korea.
Hyung Jong BaeNano Systems Institute Seoul National University Seoul 08826 South Korea.
Daewon LeeInterdisciplinary Program in Bioengineering Seoul National University Seoul 08826 South Korea.
Sumin LeeDepartment of Electrical and Computer Engineering Seoul National University Seoul 08826 South Korea.
Jiyun KimSchool of Materials Science and Engineering Ulsan National Institute of Science and Technology Ulsan 44919 South Korea.
Sunghoon KwonDepartment of Electrical and Computer Engineering Seoul National University Seoul 08826 South Korea.ORCID https://orcid.org/0000-0003-3514-1738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large-scale screening of sequential drug combinations, wherein the dynamic rewiring of intracellular pathways leads to promising therapeutic effects and improvements in quality of life, is essential for personalized medicine to ensure realistic cost and time requirements and less sample consumption. However, the large-scale screening requires expensive and complicated liquid handling systems for automation and therefore lowers the accessibility to clinicians or biologists, limiting the full potential of sequential drug combinations in clinical applications and academic investigations. Here, a miniaturized platform for high-throughput combinatorial drug screening that is "pipetting-free" and scalable for the screening of sequential drug combinations is presented. The platform uses parallel and bottom-up formation of a heterogeneous drug-releasing hydrogel microarray by self-assembly of drug-laden hydrogel microparticles. This approach eliminates the need for liquid handling systems and time-consuming operation in high-throughput large-scale screening. In addition, the serial replacement of the drug-releasing microarray-on-a-chip facilitates different drug exchange in each and every microwell in a simple and highly parallel manner, supporting scalable implementation of multistep combinatorial screening. The proposed strategy can be applied to various forms of combinatorial drug screening with limited amounts of samples and resources, which will broaden the use of the large-scale screening for precision medicine.

Indexed as

drug‐laden hydrogelencoded microparticlehigh‐throughput screeningself‐assemblysequential combination

Identifiers

PMID30775230
PMCPMC6364496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.